Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 5
2006 2
2007 4
2008 7
2009 10
2010 13
2011 16
2012 13
2013 8
2014 17
2015 19
2016 14
2017 17
2018 20
2019 20
2020 19
2021 17
2022 24
2023 21
2024 24
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
Management of Crohn Disease: A Review.
Cushing K, Higgins PDR. Cushing K, et al. Among authors: higgins pdr. JAMA. 2021 Jan 5;325(1):69-80. doi: 10.1001/jama.2020.18936. JAMA. 2021. PMID: 33399844 Free PMC article. Review.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, Hébuterne X, D'Haens G, Nakase H, Panés J, Higgins PDR, Juillerat P, Lindsay JO, Loftus EV Jr, Sandborn WJ, Reinisch W, Chen MH, Sanchez Gonzalez Y, Huang B, Xie W, Liu J, Weinreich MA, Panaccione R. Danese S, et al. Among authors: higgins pdr. Lancet. 2022 Jun 4;399(10341):2113-2128. doi: 10.1016/S0140-6736(22)00581-5. Epub 2022 May 26. Lancet. 2022. PMID: 35644166 Clinical Trial.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel JF, Higgins PDR. Berinstein JA, et al. Among authors: higgins pdr. Am J Gastroenterol. 2024 Mar 27:10.14309/ajg.0000000000002674. doi: 10.14309/ajg.0000000000002674. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38275248
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.
Sandborn WJ, Ghosh S, Panes J, Schreiber S, D'Haens G, Tanida S, Siffledeen J, Enejosa J, Zhou W, Othman AA, Huang B, Higgins PDR. Sandborn WJ, et al. Among authors: higgins pdr. Gastroenterology. 2020 Jun;158(8):2139-2149.e14. doi: 10.1053/j.gastro.2020.02.030. Epub 2020 Feb 22. Gastroenterology. 2020. PMID: 32092309 Free article. Clinical Trial.
Charting human development using a multi-endodermal organ atlas and organoid models.
Yu Q, Kilik U, Holloway EM, Tsai YH, Harmel C, Wu A, Wu JH, Czerwinski M, Childs CJ, He Z, Capeling MM, Huang S, Glass IA, Higgins PDR, Treutlein B, Spence JR, Camp JG. Yu Q, et al. Among authors: higgins pdr. Cell. 2021 Jun 10;184(12):3281-3298.e22. doi: 10.1016/j.cell.2021.04.028. Epub 2021 May 20. Cell. 2021. PMID: 34019796 Free PMC article.
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
Elmunzer BJ, Foster LD, Serrano J, Coté GA, Edmundowicz SA, Wani S, Shah R, Bang JY, Varadarajulu S, Singh VK, Khashab M, Kwon RS, Scheiman JM, Willingham FF, Keilin SA, Papachristou GI, Chak A, Slivka A, Mullady D, Kushnir V, Buxbaum J, Keswani R, Gardner TB, Forbes N, Rastogi A, Ross A, Law J, Yachimski P, Chen YI, Barkun A, Smith ZL, Petersen B, Wang AY, Saltzman JR, Spitzer RL, Ordiah C, Spino C, Durkalski-Mauldin V; SVI Study Group. Elmunzer BJ, et al. Lancet. 2024 Feb 3;403(10425):450-458. doi: 10.1016/S0140-6736(23)02356-5. Epub 2024 Jan 11. Lancet. 2024. PMID: 38219767 Free PMC article. Clinical Trial.
Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD.
Huang W, Zhang Y, Das NK, Solanki S, Jain C, El-Derany MO, Koo I, Bell HN, Aabed N, Singhal R, Castillo C, Buscher K, Ying Y, Dimitroff J, Sharma A, Shi J, Hogan SP, Dame MK, Higgins PDR, Colacino JA, Oh TG, Spence JR, Patterson AD, Greenberg AS, Greenson JK, Nusrat A, Shah YM. Huang W, et al. Among authors: higgins pdr. Nat Metab. 2025 Jul;7(7):1358-1374. doi: 10.1038/s42255-025-01313-x. Epub 2025 Jun 26. Nat Metab. 2025. PMID: 40571769
Reply.
Berinstein JA, Steiner CA, Higgins PDR. Berinstein JA, et al. Among authors: higgins pdr. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1303-1304. doi: 10.1016/j.cgh.2020.08.023. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248182 No abstract available.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.
Sands BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, Fischer M, Jairath V, Hirai F, D'Haens G, Belin RM, Miller D, Gomez-Valderas E, Naegeli AN, Tuttle JL, Pollack PF, Sandborn WJ. Sands BE, et al. Among authors: higgins pdr. Gastroenterology. 2022 Feb;162(2):495-508. doi: 10.1053/j.gastro.2021.10.050. Epub 2021 Nov 5. Gastroenterology. 2022. PMID: 34748774 Free article. Clinical Trial.
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
D'Haens G, Higgins PDR, Peyrin-Biroulet L, Sands BE, Lee S, Moses RE, Redondo I, Escobar R, Hunter Gibble T, Keohane A, Morris N, Zhang X, Arora V, Kobayashi T. D'Haens G, et al. Among authors: higgins pdr. Inflamm Bowel Dis. 2024 Dec 5;30(12):2335-2346. doi: 10.1093/ibd/izae004. Inflamm Bowel Dis. 2024. PMID: 38271613 Free PMC article. Clinical Trial.
259 results